Decision curve analysis was conducted to assess clinical utility.<h4>Results</h4>Significant differences in DKI and DCE-MRI parameters were observed between TERT promoter mutant and wild-type gliomas (<i>p</i> < 0.05). This evidence concerns the gene TERT and central nervous system cancer.